Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$322K Buy
6,137
+742
+14% +$39.2K 0.01% 965
2026
Q1
$298K Sell
5,395
-223
-4% -$12.1K 0.01% 878
2025
Q4
$276K Buy
+5,618
New +$262K 0.01% 803

Other funds holding GSK

Savvy Advisors Inc's GSK Position: Q2 2026 in Review

Savvy Advisors Inc increased its GSK (GSK) stake by 14% in Q2 2026, buying an estimated $39.2K and bringing the position to 6,137 shares worth $322K. The position accounts for 0.01% of the portfolio, ranked #965.

Savvy Advisors Inc first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Savvy Advisors Inc held 6,137 shares of GSK worth $322K as of Q2 2026.
  • Savvy Advisors Inc bought 742 GSK shares in Q2 2026, an estimated $39.2K.
  • GSK made up 0.01% of Savvy Advisors Inc's portfolio in Q2 2026, its #965 holding.
  • Savvy Advisors Inc first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
  • 1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Savvy Advisors Inc's 13F filing for Q2 2026, filed 3 Aug 2026.